Synthetic cathinones and related agents represent an international drug abuse problem, and at the same time an important class of clinically useful compounds. Structure-activity relationship studies are needed to elucidate molecular features underlying the pharmacology of these agents. Illicit methcathinone (i.e., MCAT), the prototype of the synthetic cathinone class, exists as a racemic mixture. Though the differences in potency and target selectivity between the positional and optical isomers of synthetic cathinones and related agents have been demonstrated to have important implications for abuse and therapeutic potential, the two MCAT isomers have never been directly compared at their molecular targets: the monoamine transporters (MATs). Additionally, previous studies have found that the carbonyl oxygen atom can be replaced with a methoxy group, but this results in two chiral centers (i.e., four possible optical isomers for synthesis and evaluation). Here, the individual isomers of MCAT, their racemate, and achiral MCAT analogs were prepared where necessary, and examined in vitro and in silico at the MATs. All agents were active as substrates, with a rank order of potency suggesting that α-position chirality, in either configuration, is favored but not required, with the S(-) configuration slightly preferred. Either chiral center removal approach resulted in a reduction in potency, suggesting both favorable interactions with the α-methyl, and limited bulk tolerance. To further investigate this possibility, docking studies were conducted using homology models of the MATs. Common binding modes were identified that were similar to the binding mode of S(+)amphetamine co-crystallized at drosophila DAT. Taken together, these studies supported our conclusions, as steric hindrance was observed in the α-methyl region of the proposed binding site for the R(+)MCAT isomer. Inclusion of the original synthetic cathinones among Schedule I controlled substances has driven the clandestine development of a second generation of agents, resulting in an array of new synthetic cathinones diverse in structure and effect.Pyrrolidinophenones are a major constituent of second-generation bath salts. Little is known about their structure-activity relationships. Here, we have synthesized and examined a series of aryl-substituted pyrrolidinophenone analogs, as well as an achiral pyrrolidinophenone analog, utilizing novel synthetic chemistry and an innovative cell-based epifluorescence Ca2+ imaging technique. Herein, we evaluated the neurochemical properties of these novel compounds at the dopamine transporter (DAT), considered to exert a major role in actions of drugs of abuse. For future structure-activity relationship studies, additional analogs of synthetic cathinone-related agents were produced using novel synthetic approaches, including analogs and isomers of known amphetamine drugs of abuse. Finally, though much has been learned about the role of the dopamine and serotonin transporters in the mechanisms of action of synthetic cathinones, the role of the norepinephrine transporter is poorly understood. Homology models of the human norephinephrine transporter were built and docking studies conducted to inform the study of MAT ligand selectivity, activity, and binding. In conclusion, these studies represent progress towards the establishment of comprehensive structure-activity relationships for synthetic cathinones and related agents. Particular emphasis was placed on the SAR of the phenylalkylamine α-carbon in the synthetic cathinone context, and the role of the norepinephrine transporter in their activity.

Le monoxyde d'azote (NO*) et l'anion peroxynitrite (ONOO−) sont deux molécules jouant un rôle clé dans de nombreuses pathologies dont certains cancers, les maladies de Parkinson et Alzheimer, ainsi que les traumatismes crâniens. Ce travail décrit le développement de capteurs électrochimiques permettant la détection simultanée de ces deux analytes d'intérêt biologique. Pour atteindre cet objectif, des dispositifs intégrant plusieurs réseaux d'ultramicroélectrodes (UMEs) d'or ont été fabriqués, à l'aide de techniques photolithographiques. La caractérisation électrochimique de ces réseaux montre qu'ils permettent d'améliorer la sensibilité des mesures, en comparaison avec des UMEs individuelles. Afin de rendre la mesure de NO* sélective vis-à-vis des interférents biologiques, nous avons d'abord étudié l'influence de plusieurs types de membranes électropolymérisées à la surface des électrodes. Ceci nous a permis d'identifier une combinaison de membranes de polyeugénol et polyphénol conférant une bonne sélectivité au capteur. Par la suite, nous nous sommes intéressés à la mise au point d'une méthode de détection électrochimique de ONOO−, basée sur la réduction de son acide conjugué à une électrode d'or non modifiée. À la suite de ces études, la détection électrochimique simultanée de NO* et ONOO− a été réalisée dans des solutions synthétiques. Enfin, nous décrivons la détection de NO* produit par des cellules vivantes, les macrophages RAW 264.7.

Les flavonoïdes sont des antioxydants issus du monde végétal, dont les effets protecteurs sur l'organisme ne sont plus à démontrer, ce qui leur a valu le qualificatif d'" alicament ". Le ferrocène est un complexe organométallique stable et lipophile, possédant un couple redox FeII / FeIII stable. Les molécules bio-actives contenant une entité ferrocéniques possèdent de nouvelles activité biologique. Par exemple, le ferrocène peut permettre d'augmenter l'activité et le spectre thérapeutique de molécules existantes, mais aussi induire des activités biologiques inédites. Ce travail a pour but de rassembler ces deux entités actives sur le plan redox afin de créer de nouvelles classes de molécules bioactives. Nous explorerons donc la conception, la synthèse, ainsi que les propriétés chimiques et biologiques de diverses sous-classes de flavonoïdes fonctionnalisés par le ferrocène. Nous verrons que l'accès à ces dérivés utilise des protocoles de synthèse originaux, et les dérivés eux-mêmes présentent des intérêts particuliers sur une variété de cibles biologiques : le virus HIV, le cancer ou encore les staphylocoques.

The first part of the thesis deals with the synthesis and biological evaluation of new platelets aggregation inhibitors, based on 12-HETE, 13-HODE and their analogues. In the second part we are interested in novel methodologies for the preparation of CF₂-containing molecules : First, a flexible strategy for the synthesis of gem-difluoro-bisarylic derivatives and heteroaromatic analogues was designed based on the easy synthesis and the reactivity of gem-difluoro propargylic intermediates, which by Diels-Alder cycloaddition and 1,3-dipolar cycloadditions afforded respectively the bisarylic and mixed arylic heteroarylic scaffolds. In addition, two small libraries were constructed around a bisarylic scaffold as representative examples. Second, we were interested in the synthesis of optically active functionalized molecules containing a gem-difluoro group, using asymmetric organocatalysis protocols. After preparation of the gem-difluoro enals, from their difluoropropargylic precursors, asymmetric organocalytic Diels-Alder cycloaddition and 1,4-conjugated additions were successfully performed.

The aim of the work was to design, manufacture, and characterize targeted multi-component dry powder aerosols of (non-destructive) mucolytic agent (mannitol), antimicrobial drug (tobramycin or azithromycin), and lung surfactant mimic phospholipids (DPPC:DPPG=4:1 in molar ratio). The targeted dry powder for inhalation formulation for deep lung delivery with a built-in rationale of specifically interfering several disease factors of chronic infection diseases in deep lungs such as cystic fibrosis, pneumonia, chronic bronchitis, and etc. The dry powder aerosols consisting of selected chemical agents in one single formulation was generated by using spray drying from organic solution. The physicochemical properties of multi-component dry powder inhaler (DPI) formulation were characterized by a number of techniques. In addition, the in vitro aerosol dispersion performance, storage stability test, and in vitro drug release of selected spray-dried (SD) multi-component systems were conducted. The physicochemical study revealed that multi-component aerosol particles possessed essential particle properties suitable for deep lung delivery. In general, the multi-component particles (typically 0.5 to 2 µm) indicated that the designed SD aerosol particles could potentially penetrate deep lung regions (such as respiratory bronchiolar and alveolar regions) by sedimentation and diffusion, respectively. The essential particle properties including narrow size distribution, spherical particle and smooth surface morphologies, and low water content (or water vapor sorption) could potentially minimize interparticulate interactions. The study of in vitro aerosol dispersion performance showed that majority of SD multi-component aerosols exhibited low values (less than 5µm) of MMAD, high values (approximately above 30% up to 60.4%) of FPF, and high values (approximately above 90%) of ED, respectively. The storage stability study showed that azithromycin–incorporated multi-component aerosol particles stored at 11 and 40% RH with no partial crystallization were still suitable for deep lung delivery. Compared to SD pure azithromycin particles, the azithromycin-incorporated multi-component particles exhibited an enhanced initial release. The targeted microparticulate and nanoparticulate multi-component dry powder aerosol formulations with essential particle properties for deep lung pulmonary delivery were successfully produced by using spray drying from organic solution. The promising experimental data suggest the multi-component formulations could be further investigated in in vivo studies for the purpose of commercialization.

L'apparition de métastases est souvent le signe d'un mauvais pronostic vital pour les personnes atteintes d'un cancer. Ce processus de formation de métastase est un phénomène complexe dans lequel la migration cellulaire est un facteur clé.De récentes études ont montré que le canal SK3 (canal potassique de faible conductance dont l'activité dépend de la concentration cytosolique en calcium) était exprimé dans des cellules cancéreuses à fort pouvoir métastatique et leur conférait des capacités de migration accrues. Cette protéine constitue donc une nouvelle cible thérapeutique très intéressante pour agir sur la dissémination de cellules cancéreuses.Les objectifs de ces travaux de thèse ont permis de mettre en oeuvre deux stratégies visant à inhiber l'activité de ce canal potassique SK3.L'édelfosine, un glycérolipide à tête phosphocholine, a rapidement été reconnue comme étant un inhibiteur efficace de l'activité de ce canal. Cependant les effets secondaires induits par cette molécule ont conduit à rechercher des analogues moins toxiques et tout aussi efficaces. Des études structures-activité menées au sein du laboratoire ont permis de développer un nouveau glycérolipide à tête lactose, l'ohmline. Dans le but de compléter cette étude, nous avons réalisé la synthèse de glyco-glycérolipides et de glycophospho-glycérolipides et avons montré leur capacité à inhiber la protéine SK3 et à réduire la migration cellulaire SK3 dépendante.Une seconde stratégie vise à l'utilisation possible d'ARN interférents pour bloquer l'expression de la protéine SK3. Dans ce but, nous nous sommes intéressés à la synthèse et à l'incorporation, dans des formulations de lipides cationiques utilisés pour la transfection, de lipides neutres portant des motifs anisamides, ligands spécifiques des récepteurs sigma surexprimés dans des lignées cellulaires de tumeurs exprimant SK3. La synthèse de lipophosphoramides comportant un motif anisamide est présentée suivie de leur utilisation dans des expériences de transfection modèles (vectorisation d'ADN plasmidique) afin d'évaluer l'efficacité du ciblage engendré par le motif anisamide.

Suite au succès clinique des composés du platine (cisplatin et de ses dérivés) en tant qu’agent anticancéreux, la chimie inorganique médicinale a connu un essor considérable offrant ainsi une alternative à la conception d'agents thérapeutiques. Bien que le cisplatin et ses dérivés soient sans doute une des classes la plus réussie de médicaments anticancéreux, leur utilisation n’est pas efficace contre tous les types de cancer. De plus, ils sont à l’origine d’effets secondaires très invalidants (neurotoxicité, néphrotoxicité, perte de poids, nausées…) et sont également inactifs contre certains cancers présentant une résistance innée ou induite. Par conséquent, la recherche a développé des composés possédant des activités améliorées et des profils de toxicité plus acceptables. Ceci a ainsi stimulé l'intérêt pour les complexes contenant d'autres métaux de la mine du platine tels que le ruthénium, car ces composés présentent une plus faible toxicité que les complexes existants. Certains composés du ruthénium ont déjà montré une activité anticancéreuse prometteuse et deux complexes du RuIII le trans-[RuCl4-(DMSO)(Im)]ImH (NAMI-A) et le trans-[RuCl4(Ind)2]IndH (KP1019) sont entrés récemment en phase clinique.Dans le but d’améliorer l’activité et de réduire les effets secondaires des agents anticancéreux existants, le Laboratoire de Synthèses Métallo-Induites a développé depuis plusieurs années des complexes organométalliques du ruthénium RDC (Ruthenium Derivative Compound) dans lesquels un des ligands est fortement lié au métal par une liaison convalente σ C-Ru qui est elle-même stabilisée par une liaison intramoléculaire N-Ru. Cette thèse présente les avancées récentes du laboratoire dans ce domaine et plus particulièrement le développement d’une chimiothèque de RDC de seconde génération dans laquelle le ligand cyclométallé est stabilisé par deux liaisons N-Ru. Plusieurs complexes ont ainsi atteint des IC50 significativement inférieur à la micromole. En parallèle, le même type d’études a été réalisé sur des complexes de l’osmium aboutissant à une chimiothèque ODC (Osmium Derivative Compound) d’une quarantaine de composés. Cette étude est d’un intérêt particulier car non seulement elle complète la famille des RDC, mais elle permet également de vérifier l’impact du changement de métal. Les études biologiques ont ainsi montré que l'osmium présente un réel intérêt dans le développement de nouveaux médicaments antitumoraux particulièrement efficaces. Les mesures des propriétés physico-chimiques telles que le potentiel d’oxydo-réduction et la lipophilie (log(Po/w)) ont permis de corréler ces paramètres à leur activité in vitro, se rapprochant ainsi d’une éventuelle relation propriété-activité (P.A.R.). Le réel rôle du potentiel d’oxydo-réduction deviendra probablement plus clair au fur et à mesure de notre avancée dans la résolution du mécanisme d'action de ces espèces. / Since the clinical success of platinum drugs (cisplatin and its derivatives) as anticancer agent, medicinal inorganic chemistry has become a field of growing interest because it offers an alternative for the design of therapeutic agents that are not readily available to organic compounds. Although cisplatin is one of the most widely used drugs in chemotherapy, it is not effective for all types of cancer. Moreover, platinum drugs are the cause of disabling side effects (neurotoxicity, nephrotoxicity, weight loss, nausea…) and their applicability is limited by innate or induced resistance to platinum in a narrow range of tumours. Therefore, this clinical success has promoted the search for cytotoxic compounds with enhanced activities and more acceptable toxicity profiles. This has stimulated interest in complexes containing other heavy metals of the platinum group such as ruthenium because these compounds show lower toxicity than drugs based on platinum. Some ruthenium compounds have already shown promising anticancer activity and two RuIII complexes trans-[RuCl4-(DMSO)(Im)]ImH (NAMI-A and trans-[RuCl4(Ind)2]IndH (KP1019) recently enter in clinical phase for their respectively antimetastatic and cytotoxic properties.In the essential aim of increasing activity and reducing side effects of anticancer agents, the Laboratoire de Synthèses Métallo-Induites has developed for several years organometallic ruthenium compounds RDC (Ruthenium Derivative Compound) in which one of the ligand is strongly bound to the metal via a strong σ C-Ru bond and stabilized by an intramolecular N-Ru bond. This thesis presents the recent advances of the laboratory in this field and the development of a second generation RDC in which the cylometallating ligand is stabilized by two N-Ru bonds. Thus, several complexes pass the symbolic barrier of the nanomolar range for their IC50 indicating a critical improvement. At the same time, we decided to focus our studies on osmium heavier congener, not only to complete the RDC chemical library, but also to verify the impact of exchanging the metal. An extensive chemical library ODC (Osmium Derivative Compound) of forty cyclometalated osmium complexes was synthesized and evaluated in vitro. Biological studies on these ODCs showed that osmium is another metal that deserves attention for the development of new effective antitumour drugs. The measurements of physicochemical properties such as red-ox potential and lipophylicity (log(Po/w)) allowed us to tentatively correlate these parameters to the level of activity, thus approaching a possible Property-Activity Relationship (P.A.R.). More insight into the role of the red-ox potential will probably become clearer as we progress into the mechanism of action of these species.

Submitted by ANA KARLA PEREIRA RODRIGUES (anakarla_@hotmail.com) on 2017-08-04T17:21:10Z No. of bitstreams: 1 arquivototal.pdf: 15443881 bytes, checksum: a81c2afaef7e1fccdeb2543bc340d5a1 (MD5) / Made available in DSpace on 2017-08-04T17:21:10Z (GMT). No. of bitstreams: 1 arquivototal.pdf: 15443881 bytes, checksum: a81c2afaef7e1fccdeb2543bc340d5a1 (MD5) Previous issue date: 2015-08-10 / Nitroaromatic compounds derived from Morita-Baylis-Hillman reaction (RMBH) have been tested in the treatment of most neglected diseases such as malaria, Chagas disease and leishmaniasis. An important experimental observation is the relation between biological activity (measured by IC50) and reduction potential of these compounds (estimated by the cathodic and anodic peak potentials determined by electroanalytical techniques), the latter directly connected to the reduction of the nitro group (-NO2 ). For this reason, electrochemical methods have been used in order to mimic the enzymatic bioreduction of these compounds, as reported by Vasconcellos et al. (J. Braz. Chem. Soc. 23:894, 2012). The objective of this work was to develop a computational protocol to predict the reduction potential in aprotic media to support the molecular modeling of new compounds with desired pharmacological activity. The developed direct protocol (for aprotic solvents) consists of performing DFT calculations with B98, PBE1PBE or M06-2X functionals with 6-31+G(d,p) basis set and C-PCM solvation method (with standard cavitation method UFF/VdW). The results show that it is possible to predict the experimental variation of the reduction potential of at least 70 % of confidence (in a range of experimental data of only 140 mV) with absolute average errors less than 45 mV (much less than the experimental uncertainty of the absolute reaction potential of hydrogen electrode, approximately 400 mV) and standard deviation of about 35 mV (inferior to 1,0 kcal/mol). The application of direct protocol for a series of 65 uncorrelated molecules, whose reduction potentials vary in a range of more than 6 V, provided a model with more than 99% of predictive power. From the application of the protocol to a series of 40 molecules, for which experimental results are not available, it was possible to predict that some of these structures may have more favorable potentials to bioreduction process than the systems used in the calibration step, which makes them candidates for new drugs. / Compostos nitroaromáticos derivados da reação de Morita-Baylis-Hillman (RMBH) vêm sendo testados no tratamento de doenças extremamente negligenciadas, tais como malária, doença de Chagas e leishmanioses. Uma importante observação experimental consiste na relação entre a atividade biológica (medida pelo IC50) e o potencial de redução (estimado pelos potencias de pico anódico e catódico determinados por técnicas eletroanalíticas) destes compostos, este último diretamente ligado à redução do grupo nitro (-NO2). Por esta razão, métodos eletroquímicos têm sido utilizados com o intuito de simular a biorredução enzimática destes compostos, como reportado por Vasconcellos e colaboradores (J. Braz. Chem. Soc. 23:894, 2012). O objetivo deste trabalho foi o de desenvolver um protocolo computacional para a predição de potenciais de redução em meio aprótico para auxiliar a modelagem molecular de novos compostos com a atividade farmacológica desejada. O protocolo direto desenvolvido (para solventes apróticos) consiste na realização de cálculos DFT com os funcionais B98, PBE1PBE ou M06-2X, com o conjunto de funções de base 6-31+G(d,p) e método de solvatação C-PCM (com o método de cavitação padrão UFF/VdW). Os resultados mostram que é possível prever a variação experimental do potencial de redução com pelo menos 70 % de confiança (em uma faixa de valores experimentais de apenas 140 mV) e erros médios absolutos inferiores a 45 mV (muito inferior à incerteza experimental do potencial de redução absoluto do eletrodo de hidrogênio, que é de cerca de 400 mV) e desvio-padrão de cerca de 35 mV (inferior a 1,0 kcal/mol). A aplicação do protocolo direto a uma série de 65 moléculas não-correlacionadas, cujos potenciais de redução variam em uma faixa de mais de 6 V, forneceu um modelo com mais de 99 % de poder preditivo. A partir da aplicação do protocolo a uma série de 40 moléculas, para as quais ainda não estão disponíveis resultados experimentais, foi possível prever que algumas destas estruturas podem possuir potenciais mais favoráveis ao processo de biorredução que os estudados na etapa de calibração, o que as tornam candidatos à novos fármacos.

Made available in DSpace on 2015-05-14T13:21:21Z (GMT). No. of bitstreams: 1 ArquivoTotal.pdf: 14314411 bytes, checksum: 28743a0226eb51126ce933c575333208 (MD5) Previous issue date: 2013-08-02 / Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - CAPES / This work is described the synthesis of ten new tetrahydropyran derivatives (compounds 42-51) designed from (±)-Naproxen structure utilizing the Prins reaction of cyclization as the key step to building shaped diastereoselective 2,4- cis and 2,4,6-cis rings tetrahydropyran, with overall yields between 62 - 65%. These new tetrahydropyran derivatives were in vivo bioevaluated on antinociceptive effect in the acetic acid-induced abdominal writhing test, the tail flick test, the rota-rod performance and open field tests, and all these new compounds showed greater antinociceptive activity compared to compound (±)- 1a, highlighting high activity tetraidropirânico derivative (±)-49, which showed 87.5% of inhibition, whereas compound (±)-1a gave only 14% inhibition in in the acetic acid-induced abdominal writhing test. Moreover, the (tail-flick test) indicated compounds (±)-46 and (±)-49 as the most actives, and all compounds showed antinociceptive activity (except compound (±) -51) without harming the motor impairment and without showing toxicity in mice. In continuation to this work, there was the synthesis of new hybrid molecules based on the structure of six non-steroidal anti-inflammatory drugs with a portion tetrahydropyran using molecular hybridization strategy. These new hybrid tetrahydropyran (74 - 79) were obtained in yields between (70 - 93%). Preliminary studies antinociceptive effect in the acetic acid-induced abdominal writhing test in the compounds (74 - 79) showed that all tetrahydropyran derivatives were more efficacious (lower ED50) and their precursors drugs and no sign of intoxication were observed in the animals. / Neste trabalho, é descrito a síntese de 10 novos derivados tetraidropirânicos compostos (42 51) planejados a partir da estrutura do (±)-Naproxeno, utilizando a reação de ciclização de Prins como etapa chave para a construção em forma diastereosseletiva 2,4-cis e 2,4,6-cis de anéis tetraidropirânicos, com rendimentos globais entre 62 65%. Estes novos derivados tetraidropirânicos foram bioavaliados in vivo em testes de contorções abdominais, retirada de cauda, desempenho no rota-rod e campo aberto, sendo que todos estes compostos apresentaram uma maior atividade antinociceptiva em relação ao composto (±)-1a, com destaque para a alta atividade do derivado tetraidropirânico (±)-49, que apresentou 87,5% de inibição, enquanto que o composto (±)-1a apresentou apenas 14% de inibição no teste de contorções abdominais induzida por ácido acético. Além disso, os testes de retirada de cauda indicaram os compostos (±)-46 e (±)-49 como os mais ativos, sendo que todos os compostos apresentaram atividade antinociceptiva (exceto composto (±)-51) sem prejudicar o comprometimento motor e sem demonstrar toxicidades em camundongos. Em continuação ao nosso trabalho, realizou-se a síntese de moléculas híbridas inéditas baseadas na estrutura de seis fármacos antiinflamatórios não esteroidais com uma porção tetraidropirânica utilizando a estratégia de hibridização molecular. Estes novos derivados tetraidropirânicos híbridos (74 79) foram obtidos em rendimentos entre 70 93%. Estudos preliminares realizados em teste contorções abdominais induzidas por ácido acético realizados nos compostos (74 79) revelaram que todos os derivados tetraidropirânicos foram mais eficazes (DE50 menor) que os seus fármacos percusores e nenhum sintoma de intoxicação foi observado nos animais.

Made available in DSpace on 2015-05-14T13:21:40Z (GMT). No. of bitstreams: 1 arquivototal.pdf: 9887169 bytes, checksum: df02b626a4888063d509afbbb46317e8 (MD5) Previous issue date: 2014-08-25 / Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - CAPES / This work was presented using the technique of molecular hybridization which is a classic strategy in medicinal chemistry and useful in the design of new drugs, consisting of the covalent joining of two or more fragments known pharmacophoric or already present recognized therapeutic activities. Described the technique of extraction, isolation and purification of piperine 6 with 2% yield, with the same natural molecule mostly present in black pepper, where studies have shown a variety of biological activities as analgesic, anti-inflammatory, anti-thermal, antitumor, antifungal, antichagasic, insecticide, leishmanicidal, among others. Next, was performed the synthesis of the respective piperic acid 12 obtained via basic hydrolysis with 87% yield. A series of alcohols tetrahydropyran derivatives replaced (33, 34, 37, 38, 79 and 80) were synthesized in good yields (76% -100%), with synthetic route and potent antinociceptive already described by our group research. The Prins cyclization reaction was used as key step to build diastereoselective 2,4-cis and 2,4,6-cis tetrahydropyranyl rings. Subsequently, we performed the synthesis of 6 novel hybrid molecules (64, 65, 66, 67, 68 and 69), based on the structure of an analog of piperine (piperic acid) with 6 alcohols substituted tetrahydropyran derivatives, using the classical approach molecular hybridization by Steglich esterification reaction to join the two portions with relatively good yields (42% - 78%), which was the intention enhance the analgesic activity by these two chemical entities. All molecular hybrids were characterized by spectroscopic (1H and 13C) and IR / Neste trabalho foi apresentado o uso da técnica de hibridização molecular que é uma estratégia clássica em química medicinal e bastante útil na concepção de novos fármacos, consistindo na junção covalente de dois ou mais fragmentos reconhecidamente farmacofóricos ou que já apresentem atividades terapêuticas reconhecidas. Descreveu-se a técnica de extração, isolamento e purificação da piperina 6 com 2% de rendimento, sendo a mesma uma molécula natural presente principalmente na pimenta preta, onde estudos mostraram uma série de atividades biológicas como, analgésico, antiinflamatório, antitérmico, antitumoral, antifúngico, antichagásico, inseticida, leishmanicida, dentre outras. Em seguida, foi realizado a síntese do seu respectivo ácido pipérico 12 obtido via hidrólise básica com 87% de rendimento. Uma série de derivados álcoois tetraidropiranos substituídos (33, 34, 37, 38, 79 e 80) foram sintetizados em bons rendimentos (76%-100%), com rota sintética e potente atividade antinociceptiva já descritas pelo nosso grupo de pesquisa. A reação de ciclização de Prins foi usada como etapa chave para a construção, em forma diastereosseletiva 2,4-cis e 2,4,6-cis, dos anéis tetraidropiranos. Posteriormente, realizou-se a síntese de 6 moléculas híbridas inéditas (64, 65, 66, 67, 68 e 69), baseadas na estrutura de uma análogo da piperina (ácido pipérico) com os 6 derivados álcoois tetraidropiranos substituídos, utilizando a estratégia clássica de hibridização molecular através da reação de esterificação de Steglich para unir as duas porções, com rendimentos relativamente bons (42%-78%), onde o intuito foi potencializar a atividade analgésica apresentada por estas duas entidades químicas. Todos os híbridos moleculares foram caracterizados pelas técnicas de espectroscopia (1H e 13C) e infravermelho